NASDAQ: SAVA
- Last Close 17.54
- Sector Healthcare
- Industry Biotechnology
- Investment Style Small Growth
- Day Range 17.45 – 17.96
- Year Range 16.55 – 50.77
- Market Cap 736.1537 Mil
- Volume / Avg 353,168.0 / 927,951.2
- Price / Sales —
- Price / Book 4.10
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis SAVA
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
About Quantitative Ratings
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Unlock Our Full Analysis With Morningstar Investor
Company Profile SAVA
Business Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.
Contact
6801 N. Capital of Texas Highway, Suite 300, Building 1
Austin, TX, 78731
Austin, TX, 78731
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
Cassava Sciences Inc
XNAS: SAVA
| Aclaris Therapeutics Inc
XNAS: ACRS
| Castle Biosciences Inc
XNAS: CSTL
| Biora Therapeutics Inc Ordinary Shares
XNAS: BIOR
| |
Price
| 17.54 | 6.65 | 16.52 | 2.13 |
Currency
| USD | USD | USD | USD |
Change
| −$0.14 (0.79%) | −$0.17 (2.49%) | −$0.14 (0.84%) | −$0.06 (2.74%) |
Market Cap
| 736.15 Mil | 470.78 Mil | 442.90 Mil | 49.69 Mil |
Industry
| Biotechnology | Diagnostics & Research | Diagnostics & Research | Biotechnology |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Cassava Sciences Inc Stock
No. SAVA does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
SAVA’s market cap is 736.15 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
SAVA’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
SAVA’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare SAVA’s historical performance against its industry peers and the overall market.